| ASSET | YEAR | % RETURN |
|---|---|---|
Avidity Biosciences (RNA) | 2023 | -59.81% |
Bilibili (BILI) | 2023 | -52.24% |
JD Inc Adr (JD) | 2023 | -49.44% |
Ubiquiti Networks (UI) | 2023 | -48.43% |
Moderna (MRNA) | 2023 | -45.01% |
Dollar General (DG) | 2023 | -44.46% |
Estee Lauder Companies (EL) | 2023 | -42.02% |
Pfizer (PFE) | 2023 | -41% |
Summit Therapeutics (SMMT) | 2023 | -39.86% |
ZoomInfo Technologies (GTM) | 2023 | -39.71% |
First Horizon National (FHN) | 2023 | -39.44% |
Chewy (CHWY) | 2023 | -37.77% |
Albemarle (ALB) | 2023 | -33.5% |
Illumina (ILMN) | 2023 | -32.05% |
Texas Pacific Land Trust (TPL) | 2023 | -31.31% |
BioNTech SE (BNTX) | 2023 | -30.99% |
Tower Semiconductor (TSEM) | 2023 | -29.6% |
Globus Medical (GMED) | 2023 | -29.08% |
Insulet (PODD) | 2023 | -27.55% |
Royalty Pharma (RPRX) | 2023 | -27.54% |
Hormel Foods (HRL) | 2023 | -27.41% |
Nextera Energy (NEE) | 2023 | -25.98% |
Bristol-Myers Squibb (BMY) | 2023 | -25.95% |
Genmab A-S (GMAB) | 2023 | -25.94% |
Alcoa (AA) | 2023 | -24.83% |
Large-cap stocks are treated as having a market cap of $10B+.
